# Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease

Page: https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep191-emily-conley-on-small-molecules-to-correct-a-rare-kidney-disease
Text version: https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep191-emily-conley-on-small-molecules-to-correct-a-rare-kidney-disease.md
Podcast: [The Long Run with Luke Timmerman](https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799)
Published: 2025-12-15T16:09:02+00:00
Episode link: https://soundcloud.com/longrunpodcast/ep191-emily-conley-on-small-molecules-to-correct-a-rare-kidney-disease
Audio file: https://feeds.soundcloud.com/stream/2230123736-longrunpodcast-ep191-emily-conley-on-small-molecules-to-correct-a-rare-kidney-disease.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep191-emily-conley-on-small-molecules-to-correct-a-rare-kidney-disease
Duration seconds: 4054

## Resource

Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep191-emily-conley-on-small-molecules-to-correct-a-rare-kidney-disease/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep191-emily-conley-on-small-molecules-to-correct-a-rare-kidney-disease.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.